SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Quince Therapeutics Price Target Announced at $70.00/Share by Rodman & Renshaw

Ratings actions from Benzinga: GMT) Quince Therapeutics Initiated at Buy by Rodman & RenshawRatings actions from Benzinga

QNCX

Related stories